Articles

http://www.businesswire.com/news/home/20160505005647/en/Allurion-Technologies%E2%80%99-Elipse%E2%84%A2-Intragastric-Balloon-Receives-Prestigious WELLESLEY, Mass.—(BUSINESS WIRE)—Allurion Technologies announced today that its flagship product, Elipse, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Elipse is the world’s first procedureless™ intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is the first intragastric balloon to receive this award. Elipse received European Union CE marking in late 2015 and is now available at leading weight loss

FDA Approves Non-Surgical Solution ORBERA™ To Assist Patients With Weight Loss The U.S. Food and Drug Administration has approved the ORBERA™ Intragastric Balloon to assist adult patients suffering from obesity in losing and maintaining weight loss. Obesity affects more than 78.6 million U.S. adults and is one of the leading causes of preventable deaths in the U.S. In 2008, an estimated $147 billion was spent in medical costs for obesity. If obesity trends continue, it’s

FDA APPROVES THE RESHAPE™ INTEGRATED DUAL BALLOON SYSTEM, A FIRST-OF-ITS-KIND NON-SURGICAL WEIGHT LOSS PROCEDURE FOR PEOPLE WITH MILD TO MODERATE OBESITY • Next generation dual balloon designed to create a feeling of fullness while providing patient comfort and safety • Proven to provide more than twice the weight loss of diet and exercise alone • Procedure integrated with 12 months of medically-supervised nutrition and exercise coaching to help enable sustained weight loss SAN CLEMENTE, CALIF—DATE

ReShape Medical® Submits PMA Application to FDA for Non-Surgical Weight Loss Device ReShape™ Integrated Dual Balloon System to Fill Significant Gap in Obesity Treatment Spectrum PR Newswire SAN CLEMENTE, Calif., July 1, 2014 SAN CLEMENTE, Calif., July 1, 2014 /PRNewswire/ — ReShape Medical® today announced that the Company has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the ReShape Integrated Dual Balloon System, the first and only dual

http://www.mcclatchydc.com/2014/06/29/231842/a-form-of-liver-disease-has-quickly.html PITTSBURGH — Renee Terney, who traveled to Erie, Pa., earlier this month to ride the slides at Splash Lagoon, has come a long way in the 2 1/2 years since she was struck by a form of liver disease that has quickly emerged as a public health threat and a challenge to transplant programs. Blood work and other tests revealed that the Sheraden resident had non-alcoholic fatty liver disease, an accumulation of fat in

http://www.baptistleader.org/community/baptist-weight-loss-center-helps-memphis-couple

Can Weight-Loss Surgery Lower Cancer Risk for the Obese? Study found it might cut chances to levels of normal-weight people, but experts view finding with caution Can Weight-Loss Surgery Lower Cancer Risk for the Obese? By Kathleen Doheny HealthDay Reporter FRIDAY, June 13, 2014 (HealthDay News) — Weight-loss surgery may do more than lower the risk of heart problems and improve type 2 diabetes in obese patients: A new review suggests it may also lower

New Jersey Gov. Chris Christie appears to have shed as many as 85 pounds since his lap-band surgery last year and looks to be down to a healthier 230-something weight, according to experts. After a constituent remarked on the governor’s noticeably slimmed-down physique at a town hall meeting last week, POLITICO asked two experts to estimate the governor’s weight loss by comparing several pictures of him from 2011 with recent photos. “I think he is

http://www.foxnews.com/health/2014/04/14/how-obesity-may-raise-breast-cancer-risk Women who have a certain genetic marker may be at increased risk for breast cancer, especially if they are overweight or obese, a new study suggests. In the study, white women with the genetic marker were nearly 70 percent more likely to have breast cancer compared to those without the marker. And if women were overweight or obese and had the marker, their risk of breast cancer increased by 210 percent, compared with those

http://youtu.be/6vWVbG-snPI